Search - tctmd.com

Displaying 321 - 340 of 586

Sort: Relevancy | Date

News Daily News

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

L.A. McKeown

August 20, 2014

Presentation

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Presenter: Akshay Bagai

August 12, 2014

News Daily News

OCT Appears to Help Identify ACS Patients Who Can Forgo Stenting

August 07, 2014

News Daily News

La TCO Ayuda a Identificar a Pacientes SCA Aptos para Recibir un Stent

August 07, 2014

News Daily News

一次性血小板检测似乎不足以指导氯吡格雷治疗的使用

July 24, 2014

News Daily News

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

July 24, 2014

News Daily News

La Prueba de la Función Plaquetaria realizada en Un Momento dado parece No Bastar para Guiar el Tratamiento con Clopidogrel

July 24, 2014

News Daily News

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Todd Neale

July 24, 2014

News Daily News

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Todd Neale

July 24, 2014

News Daily News

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

L.A. McKeown

July 03, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Leah Lawrence

July 03, 2014

News Daily News

Los Índices de ACV Isquémicos Post-AMI Bajan y los de ACV Hemorrágicos se Mantienen Estables desde 1999

Leah Lawrence

July 03, 2014

Presentation

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Presenter: J.A. Udell

June 17, 2014

News Daily News

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Yael L. Maxwell

June 17, 2014

Presentation

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Presenter: Stefanie Schulz

May 14, 2014

News Daily News

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

May 14, 2014

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

Advertisement

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

OCT Appears to Help Identify ACS Patients Who Can Forgo Stenting

La TCO Ayuda a Identificar a Pacientes SCA Aptos para Recibir un Stent

一次性血小板检测似乎不足以指导氯吡格雷治疗的使用

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

La Prueba de la Función Plaquetaria realizada en Un Momento dado parece No Bastar para Guiar el Tratamiento con Clopidogrel

El Andamiaje Bioabsorbible tiene un Buen Rendimiento aunque Preocupa la Trombosis

Bioresorbable Scaffold Performs Well, But Thrombosis Raises Concerns

Una Estrategia de Anticoagulación Potente con Reversión Rápida Post-PCI parece Segura y Efectiva

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

Post-AMI Ischemic Stroke Rates Down, Hemorrhagic Stroke Stable Since 1999

Los Índices de ACV Isquémicos Post-AMI Bajan y los de ACV Hemorrágicos se Mantienen Estables desde 1999

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Prasugrel Efficacy in STEMI Largely Unaffected by PCI Timing

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

BRAVE 4: Prasugrel Plus Bivalirudin Fails to Mitigate Stent Thrombosis in STEMI Patients

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content